Entheon Biomedical Corp. (ENBI.CN)
CAD 0.1
(-16.67%)
CAD 0.1
(-16.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 250.32 Thousand CAD | 33.45% |
| 2022 | 187.58 Thousand CAD | 1954.57% |
| 2021 | 9130.00 CAD | 435.17% |
| 2020 | -2724.00 CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - CAD | 0.0% |
| 2024 Q1 | - CAD | 0.0% |
| 2024 Q3 | - CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 FY | 250.32 Thousand CAD | 33.45% |
| 2023 Q1 | 120 Thousand CAD | 21.3% |
| 2023 Q3 | - CAD | -100.0% |
| 2023 Q2 | 130.32 Thousand CAD | 8.6% |
| 2022 Q4 | 98.92 Thousand CAD | 36.82% |
| 2022 FY | 187.58 Thousand CAD | 1954.57% |
| 2022 Q3 | 72.3 Thousand CAD | 1413.65% |
| 2022 Q2 | 4777.00 CAD | 50.65% |
| 2022 Q1 | 3171.00 CAD | -41.2% |
| 2021 Q1 | -89.29 Thousand CAD | 0.0% |
| 2021 Q2 | 1457.00 CAD | 101.63% |
| 2021 Q3 | 2280.00 CAD | 56.49% |
| 2021 Q4 | 5393.00 CAD | 136.54% |
| 2021 FY | 9130.00 CAD | 435.17% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | -2724.00 CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 596.692% |
| Asep Medical Holdings Inc | -113.74 Thousand CAD | 320.084% |
| BetterLife Pharma Inc. | - CAD | -Infinity% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | -42 Thousand CAD | 696.007% |
| Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 55.57% |
| Defence Therapeutics Inc. | -90.92 Thousand CAD | 375.31% |
| Gemina Laboratories Ltd. | -93.36 Thousand CAD | 368.104% |
| Glow Lifetech Corp. | -505.62 Thousand CAD | 149.508% |
| Lexston Life Sciences Corp. | -26.39 Thousand CAD | 1048.409% |
| Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 44.875% |
| Doseology Sciences Inc. | -36.08 Thousand CAD | 793.723% |
| MYND Life Sciences Inc. | -332.99 Thousand CAD | 175.174% |
| Nova Mentis Life Science Corp. | 25.4 Thousand CAD | -885.33% |
| PharmaTher Holdings Ltd. | -711.00 CAD | 35307.173% |
| PreveCeutical Medical Inc. | -9856.00 CAD | 2639.803% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 57.957% |